Hip tendonitis refer to a condition in which single or many tendons connects various muscles to the hip bone, get damaged. The hip and pelvis joints supports the body weight in an upright position. The muscles present in this region are more bulky and strong, however, tendons are prone to damage with increasing age and changing lifestyle. During the last decade, the lifestyle of the people across the globe has changed dramatically. Increasing incident of sports injuries, rising geriatric population, increasing patients population suffering from rheumatoid arthritis & diabetes, and adoption of sedentary lifestyle have led to increase the prevalence of hip tendonitis, which significantly drives the market growth. According to the US centers for diseases control, over 10% of kids and teen participating in the sports suffer from minor or major types of injuries. Additionally, increasing government support for research & development of different drugs, changing lifestyle and lack of exercise have fuelled the market growth. However, long approval time for drugs and lack of precise treatment may slow the growth of the market.
Hip Tendinitis Market Research Report, By Type (Internal Snapping, External Snapping, Intra-Articular Snapping Hip), Treatment (Diagnosis, Therapy), End User (Hospitals & Clinics, Medical Research Centers, Academic Institutes) – Global Forecast Till 2023
View Reports Sample @ https://www.marketresearchfuture.com/sample_request/4764
The global hip tendinitis market is expected to grow at a CAGR of 4.55% during forecast period 2017-2023.
- Pharmaceutical companies
- Biotechnological institutes
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Medical Research Laboratories
- Market Research and Consulting Service Providers
The global hip tendinitis market is segmented on the basis of types, treatment, and end users.
On the basis of types, the market is segmented into internal snapping hip, external snapping hip, and intra-articular snapping hip.
On the basis of treatment, the market is segmented into diagnosis and therapy. The diagnosis is further segmented into physical exam, imaging tests, and others. Imaging test is further segmented into ultrasound, magnetic resonance imaging (MRI) scans, and others. The therapy is segmented into pharmacological, non-pharmacological, shock wave or surgery, medical devices, and others. The pharmacological therapy is further segmented into OTC drugs, corticosteroids injections, platelet-rich plasma (PRP), and others. The medical devices are further segmented into mechanical band, support tape, pre-cut strips, continuous rolls, and others.
On the basis of end users, the market is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
LIST OF TABLES
Table 1 Hip Tendinitis Industry Synopsis, 2017 – 2023
Table 2 Global Hip Tendinitis Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Hip Tendinitis Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Hip Tendinitis Market By Types, 2017 – 2023, (USD Million)
Table 5 Global Hip Tendinitis Market By Treatment, 2017 – 2023, (USD Million)
Table 6 Global Hip Tendinitis Market By End Users, 2017 – 2023, (USD Million)
Table 7 North America Hip Tendinitis Market By Types, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Hip Tendinitis Market
Figure 3 Segmentation Market Dynamics For Global Hip Tendinitis Market
Figure 4 Global Hip Tendinitis Market Share, By Type 2016
Figure 5 Global Hip Tendinitis Market Share, By Treatment 2016
Figure 6 Global Hip Tendinitis Market Share, By End Users, 2016
Figure 7 Global Hip Tendinitis Market Share, By Region, 2016
Request Full Report @ https://www.marketresearchfuture.com/reports/hip-tendinitis-market-4764
Key players for global hip tendinitis market
Some of the key players in the global hip tendinitis market are Almatica Pharma, Inc (U.S.), AstraZeneca (U.K.), Bayer AG (Germany), Boehringer Ingelheim Pharmaceuticals, Inc (Germany), Merck & Co., Inc (U.S.), Pfizer (U.S.), Abbott (U.S.), GlaxoSmithKline plc (U.K.), Teva Pharmaceuticals (Taiwan), Lupin Pharmaceuticals, Inc. (India), Geri-Care Pharmaceuticals. (U.S.), and Perrigo Company (U.S),
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.